Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ DEFINITION ++ Hodgkin lymphoma (HL) is a lymphoid neoplasm consisting of two distinct entities: classic Hodgkin lymphoma (cHL), accounting for 95% of cases, and nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), accounting for about 5% of cases. Both types of HL are derived from germinal center B cells. cHL is defined by the presence of the Reed-Sternberg (RS) cells or its mononuclear variant Hodgkin cells with a characteristic immunophenotype and appropriate cellular background (Figures 60–1 and 60–2). The neoplastic cells account for only 1% to 5% of cells in an affected node or tissue. HL cells secrete cytokines and chemokines, which attract multiple reactive cell types, with T cells predominating. The survival of HL cells is dependent on these cells in the microenvironment. cHL consists of four histologic subtypes that are distinguished based on microscopic appearance and relative proportions of RS cells, lymphocytes, and fibrosis: — Nodular sclerosis (~60%–65% of cases) predominates in young adults. The RS cells appear as lacunar cells. — Mixed cellularity (~25%–35% of cases) predominates in older adults. — Lymphocyte-rich (~5% of cases) is most frequent in males. — Lymphocyte-depleted is very rare. The malignant cells in NLPHL are called lymphocytic/histiocytic cells or “popcorn” cells and are embedded in B-cell–rich nodules. The distinguishing pathologic features between cHL and NLPHL are shown in Table 60–1. ++ FIGURE 60–1 High magnification of lymph node section in a patient with Hodgkin lymphoma. A Reed-Sternberg cell is in the center of the field with the classical findings of giant size compared to background lymphocytes, binucleation, and prominent eosinophilic nucleoli. Graphic Jump LocationView Full Size||Download Slide (.ppt) ++ FIGURE 60–2 Classic Hodgkin lymphoma stained with antibody to CD30. CD30 stains the Reed-Sternberg cells in this lymph node biopsy. Graphic Jump LocationView Full Size||Download Slide (.ppt) ++Table Graphic Jump LocationTABLE 60–1PATHOLOGIC FEATURES OF CLASSIC HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMAView Table||Download (.pdf) TABLE 60–1 PATHOLOGIC FEATURES OF CLASSIC HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA Classic Hodgkin Lymphoma Nodular Lymphocyte-Predominant Hodgkin Lymphoma Lymph node architecture Diffuse or nodular Nodular Malignant cells Hodgkin and Reed-Sternberg cells Lymphocyte-predominant “popcorn” cells Background cells Lymphocytes, histiocytes, neutrophils, eosinophils, plasma cells, fibroblasts Lymphocytes, histiocytes, T-cell rosettes around popcorn cells Fibrosis Common Rare CD30 + (>95%) Rare CD15 + (70%–80%) Rare CD20 Rare + (>95%) PAX5 Dim Moderate/bright OCT2 –/+ + BOB.1 –/+ + EBER Common (30%–40%) Rare EBER, Epstein-Barr virus–encoded small RNAs. +++ EPIDEMIOLOGY ++ The incidence of HL is 2 to 3/100,000 per annum in the United States and western Europe. The rate has been stable for several decades. In 2017 in the United States, there were 8260 cases of HL. An increased risk of cHL has been reported in young adults with high socioeconomic status, and the influence of environmental factors is controversial. There is a bimodal age distribution, with a ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.